NCT01263444View on ClinicalTrials.gov

Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

Brinzolamide 1% / timolol 0.5% Fixed Combination

DRUG

Habitual prostaglandin monotherapy

Topical ocular therapy used daily as prescribed

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY